Medicare Enrolled

Dr. Diana Mummert, MD

Psychiatry · Fort Worth, TX
Low-engagement
855 MONTGOMERY ST, Fort Worth, TX 76107
8177352400
In practice since 2008 (18 years)
NPI: 1295907764 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mummert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mummert? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mummert

Dr. Diana Mummert is a psychiatry specialist in Fort Worth, TX, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Mummert received a total of $5,197 from 41 pharmaceutical and/or device companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mummert is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice $5,197 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,197
Total received (2018-2024)
Avg $742/year across 7 years
Top 13% in TX for psychiatry
41
Companies
377
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,197 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,034
2023
$1,372
2022
$1,009
2021
$989
2020
$385
2019
$176
2018
$231

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$967
ITI, Inc.
$510
Sunovion Pharmaceuticals Inc.
$404
Otsuka America Pharmaceutical, Inc.
$391
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$342
Lundbeck LLC
$316
Janssen Pharmaceuticals, Inc
$289
Tris Pharma Inc
$229
AbbVie Inc.
$186
Takeda Pharmaceuticals U.S.A., Inc.
$163
Eisai Inc.
$144
Corium, LLC
$107
Alkermes, Inc.
$103
JAZZ PHARMACEUTICALS INC.
$97
Supernus Pharmaceuticals, Inc.
$82
Neos Therapeutics, LP
$81
Allergan Inc.
$77
Shire North American Group Inc
$75
Noven Therapeutics, LLC
$72
Allergan, Inc.
$58
Axsome Therapeutics, Inc.
$58
Adlon Therapeutics L.P.
$57
ARBOR PHARMACEUTICALS, INC.
$48
Vanda Pharmaceuticals Inc.
$41
Orexo US, Inc.
$36
Genentech USA, Inc.
$33
Ironshore Pharmaceuticals Inc.
$27
Indivior Inc.
$25
Amgen Inc.
$21
Lilly USA, LLC
$16
Medtronic, Inc.
$15
GlaxoSmithKline, LLC.
$14
Seqirus USA Inc
$14
Bausch Health US, LLC
$14
Almatica Pharma LLC
$14
Merck Sharp & Dohme LLC
$13
Amarin Pharma Inc.
$13
OWP Pharmaceuticals, Inc.
$13
Mannkind Corporation
$12
Novo Nordisk Inc
$11
Neuronetics, Inc.
$9
Top 3 companies account for 36.2% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · AFREZZA · APLENZIN · AZSTARYS · Adzenys XR-ODT · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · Dayvigo · Dyanavel XR · EVENITY · Evekeo · Fluad Quadrivalent · Hetlioz · Horizant · INVEGA SUSTENNA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · MYDAYIS · NEUROSTAR TMS THERAPY · Ozempic · QELBREE · REXULTI · SHINGRIX · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · Secuado · Subvenite · TRINTELLIX · TRULICITY · UBRELVY · VIIBRYD · VIVITROL · VRAYLAR · VYVANSE · Vascepa · VenaSeal · Vivitrol 380 mg · Xelstrym · Xofluza · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a psychiatry specialist in Fort Worth?
Compare psychiatrists in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
165
Per 100K population
7.7
County median income
$81,905
Nearest hospital
BAYLOR SCOTT AND WHITE SURGICAL HOSPITAL FORTWORTH
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mummert is a psychiatry specialist, with low-engagement industry engagement in the top 13% of TX peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Mummert receive payments from pharmaceutical companies?
Yes. Dr. Mummert received a total of $5,197 from 41 companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Mummert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →